Seanjari Preeti Womb Healing, L.L.C. – FDA Warning Letter, May 5, 2020
On May 8, 2020, the FDA and FTC issued a Warning Letter to Seanjari Preeti Womb Healing LLC after reviewing their website, www.seanjaripreeti.com, and YouTube channel on April 23 and May 5, 2020. The letter states that the company offers a honey product for sale in the U.S. that is intended to mitigate, prevent, treat, diagnose, or cure COVID-19.
The FDA determined this product is an unapproved new drug, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and a misbranded drug under section 502 of the FD&C Act (21 U.S.C. § 352). The introduction of this product into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act (21 U.S.C. § 331(a) and (d)).
The letter emphasizes that the FDA is taking urgent measures to protect consumers from unapproved products claiming to address COVID-19, given the public health and national emergencies declared. The company is required to immediately cease selling these unapproved and unauthorized products.
The company must email COVID-19-TASK-FORCE-CDER@fda.hhs.gov
ID · deb1cd8e-792e-46fc-aea6-ac1a8b942a5a
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.